See our latest video: "What If "
[ Ссылка ] --~--
Dr. Ross Levine, from Memorial Sloan Kettering Cancer Center, talks about the complexities of AML. He said that you need to go beyond bulk sequencing to understand clonal evolution and that through clonal analysis it is possible to intercept AML before it occurs.

Mission Bio delivers targeted solutions for high-impact applications with the Tapestri Platform. The Tapestri Platform is the industry’s first and only single-cell multi-omics platform, enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. Application areas include oncology blood cancers, solid tumors, and genome editing validation to name a few.


Learn more about Mission Bio: [ Ссылка ]

LinkedIn: [ Ссылка ]

Twitter: [ Ссылка ]

Facebook: [ Ссылка ]

Subscribe to our emails and updates: [ Ссылка ]

свернуть